Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Preferred Shares (2016 - 2025)

BioCorRx's Preferred Shares history spans 12 years, with the latest figure at $16000.0 for Q2 2025.

  • For Q2 2025, Preferred Shares rose 184.9% year-over-year to $16000.0; the TTM value through Jun 2025 reached $16000.0, up 184.9%, while the annual FY2023 figure was $16000.0, 184.9% up from the prior year.
  • Preferred Shares for Q2 2025 was $16000.0 at BioCorRx, roughly flat from $16000.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $16000.0 in Q1 2022 and bottomed at $5616.0 in Q3 2021.
  • The 5-year median for Preferred Shares is $16000.0 (2022), against an average of $11846.4.
  • The largest annual shift saw Preferred Shares crashed 64.9% in 2021 before it skyrocketed 184.9% in 2023.
  • A 5-year view of Preferred Shares shows it stood at $5616.0 in 2021, then changed by 0.0% to $5616.0 in 2022, then surged by 184.9% to $16000.0 in 2023, then changed by 0.0% to $16000.0 in 2024, then changed by 0.0% to $16000.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Preferred Shares are $16000.0 (Q2 2025), $16000.0 (Q1 2025), and $16000.0 (Q3 2024).